Prioritizing clinical trial quality assurance for photons and protons: A failure modes and effects analysis (FMEA) comparison

- Taylor, Paige A., Miles, Elizabeth, Corning, Coreen, Effeney, Rachel, Healy, Brendan, Moore, Alisha, Nakamura, Mitsuhiro, Patel, Samir, Shaw, Maddison, Stock, Markus, Lehmann, Joerg, Clark, Catharine H., Hoffmann, Lone, Kelly, Sarah M., Kry, Stephen F., Møller, Ditte Sloth, Palmans, Hugo, Akbarov, Kamal, Aznar, Marianne C., Clementel, Enrico

Report dose-to-medium in clinical trials where available; a consensus from the Global Harmonisation Group to maximize consistency

- Kry, Stephen F., Lye, Jessica, Clark, Catharine H., Andratschke, Nicolaus, Dimitriadis, Alexis, Followill, David, Howell, Rebecca, Hussein, Mohammad, Ishikawa, Masayori, Kito, Satoshi, Kron, Tomas, Lee, Jonny, Michalski, Jeff, Filippo Monti, Angelo, Reynaert, Nick, Taylor, Paige, Venables, Karen, Xiao, Ying, Lehmann, Joerg

Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines: GHG OAR consensus contouring guidance

- Mir, Romaana, Kelly, Sarah M., Ishikura, Satoshi, Kristensen, Ingrid, Kry, Stephen F., Lehmann, Joerg, Michalski, Jeff M., Monti, Angelo F., Nakamura, Mitsuhiro, Thompson, Kenton, Yang, Huiqi, Zubizarreta, Eduardo, Xiao, Ying, Andratschke, N, Miles, E, Moore, Alisha, Clark, Catharine H., Clementel, Enrico, Corning, Coreen, Ebert, Martin, Hoskin, Peter, Hurkmans, Coen W.

A virtual dosimetry audit - towards transferability of gamma index analysis between clinical trial QA groups

- Hussein, Mohammad, Clementel, Enrico, Nakamura, Mitsuhiro, Hurkmans, Coen, Clark, Catherine H., Global Quality Assurance of Radiation Therapy Clinical Trial Harmonisation Group,, Eaton, David J., Greer, Peter B., Haworth, Annette, Ishikura, Satoshi, Kry, Stephen F., Lehmann, Joerg, Lye, Jessica, Monti, Angelo F.